-
Edwards Lifesciences (EW) PT Raised to $150 at BMO Capital
-
BMO Capital Upgrades Edwards Lifesciences (EW) to Outperform
-
Notable Analyst Rating Changes 10/16: (INTC) (S) (JNPR) Upgraded; (VVUS) (ELLI) (ACI) Downgraded
-
Notable Analyst Rating Changes 04/24: (HAL) (COH) (CIT) Upgraded; (AAPL) (IRWD) (EW) Downgraded
-
Notable Analyst Rating Changes 02/01: (GME) (VZ) (CB) Upgraded; (HTSI) (ALKS) (TWC) Downgraded
-
Notable Analyst Rating Changes 01/18: (MGM) (RSH) (CREE) Upgraded; (TSN) (GOOG) (JNS) Downgraded
-
Daily State of the Markets 09/28: Second Thoughts?
-
Daily State of the Markets 09/23: Shoulda, Coulda, Woulda?
-
Notable Analyst Rating Changes 09/23: EW, MYL, NVDA, ENDP Upgraded; DYN, MO, OXPS, CVVT Downgraded
-
Notable Analyst Rating Changes 07/07: SIRI, JNPR, EMC, NUAN Upgraded; FCN, ADSK, EW, RNOW Downgraded
-
BMO Capital Downgrades Edwards Lifesciences (EW) to Market Perform
-
Notable Analyst Rating Changes 7/28: X, AA, ENOC, IR, UFS Upgraded; DB, PM, WGOV, CRM Downgraded
-
BMO Starts Edwards Lifesciences (EW) at Outperform

